Bayer | BAYN - Gross Profit On Sales

Stock Price
36.45
Daily Change
-0.17 -0.46%
Monthly
-6.69%
Yearly
58.27%
Q2 Forecast
37.49

Bayer reported EUR5.35B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Air Liquide EUR 8.65B 4.44B Dec/2024
Akzo Nobel EUR 936M 102M Dec/2025
Alcon AG USD 1.52B 58M Dec/2025
Amarin USD 23.17M 961K Dec/2025
Arkema EUR 455M 14M Jun/2025
AstraZeneca USD 12.39B 5M Dec/2025
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Corteva USD 1.5B 685M Dec/2025
Covestro EUR 488M 64M Sep/2025
Essilor EUR 8.3B 547M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.39B 147M Dec/2025
Genmab DKK 977M 13M Dec/2025
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Johnson Matthey GBP 480M 33M Jun/2024
Linde USD 3.27B 969M Dec/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 2.96B 252M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Nutrien USD 1.89B 76M Dec/2025
Philips EUR 2.29B 377M Dec/2025
PPG Industries USD 1.46B 54M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
SAP EUR 6.97B 149M Mar/2026
Solvay EUR 265M 13M Sep/2025
UCB EUR 3.19B 621M Dec/2025
Umicore EUR 308.6M 10.45M Dec/2024
Vinci EUR 2.44B 27.34B Jun/2025